Publicly available information on the Company may be found on www.sedar.com
Industry Thought Leaders Applying Vivione Biosciences Leading Edge Diagnostic Technologies to Critical Oil and Gas Operating Problems
Vivione Biosciences Announces Successful Field Deployment of RAPID-B with Greene's Energy
Vivione Biosciences Announces Preferred Vendor Arrangement With Ely and Associates
Vivione Biosciences Inc. Announces Agreement to Acquire Trillium Diagnostics
Vivione Biosciences Inc. Announces a Strategic Partnership with Sale of the RAPID-B system To AES Water Solutions
Vivione Biosciences Announces Successful Completion of Its Early-Stage Pilot Study at the Cleveland Clinic
Vivione Biosciences Engages Ardour Capital As Its Exclusive Investment Banker
Vivione Biosciences Inc. Receives AOAC Certification, Positions Brand for Fast Growth in Food Industry
Vivione Signs Strategic Alliance Agreement with IEH and Launches New Oil and Gas Product Offerings
Vivione Biosciences Inc. announces agreement with Litmus, LLC for Molecular Design Rights
Vivione Biosciences Inc. Enters Agreement with World’s Largest Public Relations Firm, Edelman
Vivione Biosciences Inc. receives coveted Letter of No Objection (LNO) designation from US Department
Vivione Biosciences signs agreement with CMS Technology
Vivione Biosciences Inc. chief executive officer interviewed by CEOCFO Magazine
Vivione Biosciences announces closing of the private placement offering with the arkansas venture capital